EXONATE LIMITED
www.exonate.comExonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration.
Read more
Exonate is an early stage biopharmaceutical company with drug discovery programmes in ophthalmology, oncology and pain. Our lead programme focuses on developing novel therapies for wet age-related macular degeneration.
Read more
Country
Industry
Employees
11-50
Founded
2013
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Operating Officer
Email ****** @****.comPhone (***) ****-****Co - Founder and Consultant
Email ****** @****.comPhone (***) ****-****Chairman of the Board
Email ****** @****.comPhone (***) ****-****Non Executive Director
Email ****** @****.comPhone (***) ****-****
Technologies
(1)
Reach decision makers at EXONATE LIMITED
Free credits every month!
EXONATE LIMITED FAQ
United Kingdom
Biotechnology Research
